Patent US4024241A successfully refreshed from Google Patents.
US4024241A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Nuclease-resistant hydrophilic complex of polyriboinosinic-polyribocytidylic acid
Assignee: United States Department of Health and Human Services
•
Filing: 1975-09-04
•
Granted: 1977-05-17
•
Expires: 1995-09-04
Abstract
Abstract A nuclease-resistant hydrophilic complex of polyriboinosinic-polyribocytidylic acid, poly-l-lysine and carboxymethylcellulose, and injectable preparations thereof in a pharmaceutically acceptable aqueous carrier such as saline solution. When administered to a primate host, the complex is effective in inducing the synthesis in such host of antiviral levels of interferon.
Inventors
- 👤 Hilton B. Levy
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-08 04:13
CPC Classifications
C; C07; C07H; C07H21/00
Claims Analysis
Total Claims: 18
Claim 1
Independent Claim
18 words
A nuclease-resistant hydrophilic complex of relatively high molecular weight polyriboinosinic-polyribocytidylic acid, relatively low molecular weight poly-l-lysine and carboxymethylcellulose.
Claim 2
Dependent Claim
18 words
A nuclease-resistant hydrophilic complex of relatively high molecular weight polyriboinosinic-polyribocytidylic acid, relatively low molecular weight poly-l-lysine and carboxymethylcellulose.
Claim 3
Dependent Claim
26 words
The complex of claim 1 wherein said polyriboinosinic-polyribocytidylic acid has a molecular weight in the range of from about 7×10 5 to about 10 7 daltons.
Claim 4
Dependent Claim
22 words
The complex of claim 1 wherein said poly-l-lysine has a molecular weight in the range of from about 2,000 to about 5,000.
Claim 5
Independent Claim
85 words
A method of preparing a nuclease-resistant hydrophilic complex of relatively high molecular weight polyriboinosinic-polyribocytidylic acid, relatively low molecular weight poly-l-lysine and carboxymethylcellulose, which comprises the steps of first mixing an aqueous solution of relatively low molecular weight poly-l-lysine with an aqueous solution of carboxymethylcellulose with stirring to thereby form a poly-l-lysine-carboxymethylcellulose intermediate complex, and thereafter adding to the resulting aqueous solution of said intermediate complex an aqueous solution of relatively high molecular weight polyriboinosinic-polyribocytidylic acid with stirring to thereby form the polyriboinosinic-polyribocytidylic acid-poly-l-lysine-carboxymethylcellulose final complex.
Claim 6
Independent Claim
85 words
A method of preparing a nuclease-resistant hydrophilic complex of relatively high molecular weight polyriboinosinic-polyribocytidylic acid, relatively low molecular weight poly-l-lysine and carboxymethylcellulose, which comprises the steps of first mixing an aqueous solution of relatively low molecular weight poly-l-lysine with an aqueous solution of carboxymethylcellulose with stirring to thereby form a poly-l-lysine-carboxymethylcellulose intermediate complex, and thereafter adding to the resulting aqueous solution of said intermediate complex an aqueous solution of relatively high molecular weight polyriboinosinic-polyribocytidylic acid with stirring to thereby form the polyriboinosinic-polyribocytidylic acid-poly-l-lysine-carboxymethylcellulose final complex.
Claim 7
Dependent Claim
46 words
The method of claim 4 wherein said intermediate complex is formed by slowly pouring said aqueous solution of poly-l-lysine into said aqueous solution of carboxymethylcellulose with stirring, and continuing said stirring for a period of time sufficient to achieve minimum turbidity in the resulting aqueous solution.
Claim 8
Dependent Claim
32 words
The method of claim 5 wherein the stirring of said aqueous solution of poly-l-lysine with said aqueous solution of carboxymethylcellulose is carried out for a period of approximately 2 to 3 days.
Claim 9
Dependent Claim
35 words
The method of claim 5 wherein the stirring of said aqueous solution of said intermediate complex with said aqueous solution of polyriboinosinic-polyribocytidylic acid is carried out for a period of approximately 2 to 3 days.
Claim 10
Dependent Claim
66 words
The method of claim 4 wherein the concentrations of said polyriboinosinic-polyribocytidylic acid, said poly-l-lysine and said carboxymethylcellulose in the respective starting aqueous solutions thereof and the relative proportions of said starting aqueous solutions are selected so as to provide in the resulting aqueous solution of said final complex 1-4 mg/ml of said polyriboinosinic-polyribocytidylic acid, 0.75-3 mg/ml of said poly-l-lysine, and 0.25-1% by weight of said carboxymethylcellulose.
Claim 11
Dependent Claim
14 words
The method of claim 8 wherein said starting aqueous solutions are all saline solutions.
Claim 12
Dependent Claim
66 words
The method of claim 9 wherein the concentrations of said polyriboinosinic-polyribocytidylic acid, said poly-l-lysine and said carboxymethylcellulose in the respective starting saline solutions thereof and the relative proportions of said starting saline solutions are selected so as to provide in the resulting saline solution of said final complex 2 mg/ml of said polyriboinosinic-polyribocytidylic acid, 1.5 mg/ml of said poly-l-lysine, and 0.5% by weight of said carboxymethylcellulose.
Claim 13
Independent Claim
49 words
A method of inducing the synthesis of interferon in a primate which comprises administering to a primate host a nuclease-resistant hydrophilic complex of relatively high molecular weight polyriboinosinic-polyribocytidylic acid, relatively low molecular weight poly-l-lysine and carboxymethylcellulose in a dose sufficient to provide an interferon-inducing amount of said polyriboinosinic-polyribocytidylic acid.
Claim 14
Independent Claim
49 words
A method of inducing the synthesis of interferon in a primate which comprises administering to a primate host a nuclease-resistant hydrophilic complex of relatively high molecular weight polyriboinosinic-polyribocytidylic acid, relatively low molecular weight poly-l-lysine and carboxymethylcellulose in a dose sufficient to provide an interferon-inducing amount of said polyriboinosinic-polyribocytidylic acid.
Claim 15
Dependent Claim
45 words
The method of claim 11 wherein said host is a non-human primate and said complex is administered from every other day to daily in a dose sufficient to provide from about 1 to about 5 mg of said polyriboinosinic-polyribocytidylic acid per kg of body weight.
Claim 16
Dependent Claim
34 words
The method of claim 12 wherein said complex is administered from every other day to daily in a dose sufficient to provide about 3 mg of said polyriboinosinic-polyribocytidylic acid per kg of body weight.
Claim 17
Dependent Claim
44 words
The method of claim 11 wherein said host is a human and said complex is administered from every other day to daily in a dose sufficient to provide from about 0.5 to about 2 mg of said polyriboinosinic-polyribocytidylic acid per kg of body weight.
Claim 18
Dependent Claim
34 words
The method of claim 14 wherein said complex is administered from every other day to daily in a dose sufficient to provide about 1 mg of said polyriboinosinic-polyribocytidylic acid per kg of body weight.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1980-05-16 | 1980-11-15 | 1981-05-17 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1984-05-16 | 1984-11-15 | 1985-05-17 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1988-05-16 | 1988-11-15 | 1989-05-17 | $7700.00 | Window Closed / Lapsed |